AND EXCHANGE COMMISSION
SECTION 13 OR 15(d) OF THE
EXCHANGE ACT OF 1934
of report (Date of earliest event reported): January 15, 2020 (January 6, 2020)
Name of Registrant as Specified in Its Charter)
or Other Jurisdiction
Avenue of the Americas, New York, NY
of Principal Executive Offices)
telephone number, including area code)
name or former address, if changed since last report)
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
registered pursuant to Section 12(b) of the Act:
of each class
of each exchange on which registered|
Stock, par value $0.0001 per share
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
growth company [ ]
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
8.01 Other Events.
January 6, 2020, and January 13, 2020, Novomic Ltd. (“Novomic”), a wholly-owned subsidiary of TechCare Corp. (the
“Company”), entered into two loan agreements with Traistman Radziejewski Fundacja Ltd. (“TRF”), a corporation
controlled by Mr. Oren Traistman, the Chairman of the Company’s Board of Directors, pursuant to which TRF agreed to loan
Novomic an aggregate amount of NIS 170,000 (approximately $49,080) on certain terms and conditions (the “Loans”).
The proceeds from the Loans will be used by Novomic for working capital and general corporate needs.
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
of the Board|
January 15, 2020